Literature DB >> 8102526

Molecular characteristics of a protease-resistant, amyloidogenic and neurotoxic peptide homologous to residues 106-126 of the prion protein.

C Selvaggini1, L De Gioia, L Cantù, E Ghibaudi, L Diomede, F Passerini, G Forloni, O Bugiani, F Tagliavini, M Salmona.   

Abstract

In the prion-related encephalopathies the prion protein is converted to an altered form, known as PrPSc, that is partially resistant to protease digestion. This abnormal isoform accumulates in the brain and its protease-resistant core aggregates extracellularly into amyloid fibrils. We have investigated the conformational properties, aggregation behaviour and sensitivity to protease digestion of a synthetic peptide homologous to residues 106-126 of human PrP, which was previously found to form amyloid-like fibrils in vitro and displayed neurotoxic activity toward primary cultures of rat hippocampal neurons. A scrambled sequence of peptide PrP 106-126 was used as a control. By circular dichroism, PrP 106-126 exhibited a secondary structure composed largely of beta-sheet, whereas the scrambled sequence of PrP 106-126 showed a random coil structure. The beta-sheet content of PrP 106-126 was much higher in 200 mM phosphate buffer at pH 5.0 than in the same buffer at pH 7.0. Laser light scattering analysis showed that PrP 106-126 aggregated immediately after dissolution in 20 mM or 200 mM phosphate buffer, pH 5.0 and 7.0, whereas scrambled PrP 106-126 did not. PrP 106-126 aggregates had an average hydrodinamic diameter of 100 nm and an average molecular weight of 12 x 10(6) +/- 30% Daltons, corresponding to the aggregation of 6000 +/- 30% molecules. Peptide PrP 106-126 showed partial resistance to digestion with Proteinase K and Pronase, whereas scrambled PrP 106-126 was completely degraded by incubation with the enzymes at 37 degrees C for 30 minutes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8102526     DOI: 10.1006/bbrc.1993.1977

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  47 in total

1.  Competing intrachain interactions regulate the formation of beta-sheet fibrils in bovine PrP peptides.

Authors:  Abdessamad Tahiri-Alaoui; Mario Bouchard; Jesús Zurdo; William James
Journal:  Protein Sci       Date:  2003-03       Impact factor: 6.725

2.  Nucleation-dependent conformational conversion of the Y145Stop variant of human prion protein: structural clues for prion propagation.

Authors:  Bishwajit Kundu; Nilesh R Maiti; Eric M Jones; Krystyna A Surewicz; David L Vanik; Witold K Surewicz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

3.  Identification of AGE-modified proteins in SH-SY5Y and OLN-93 cells.

Authors:  André K Langer; H Fai Poon; Gerald Münch; Bert C Lynn; Thomas Arendt; D Allan Butterfield
Journal:  Neurotox Res       Date:  2006-06       Impact factor: 3.911

4.  Identification of microglial signal transduction pathways mediating a neurotoxic response to amyloidogenic fragments of beta-amyloid and prion proteins.

Authors:  C K Combs; D E Johnson; S B Cannady; T M Lehman; G E Landreth
Journal:  J Neurosci       Date:  1999-02-01       Impact factor: 6.167

5.  Computational approaches to shed light on molecular mechanisms in biological processes.

Authors:  Giorgio Moro; Laura Bonati; Maurizio Bruschi; Ugo Cosentino; Luca De Gioia; Pier Carlo Fantucci; Alessandro Pandini; Elena Papaleo; Demetrio Pitea; Gloria A A Saracino; Giuseppe Zampella
Journal:  Theor Chem Acc       Date:  2007-05-01       Impact factor: 1.702

6.  Pathogenic prion protein fragment (PrP106-126) promotes human immunodeficiency virus type-1 infection in peripheral blood monocyte-derived macrophages.

Authors:  Silvia M Bacot; Gerald M Feldman; Kenneth M Yamada; Subhash Dhawan
Journal:  Virology       Date:  2015-01-09       Impact factor: 3.616

7.  The mechanism of membrane disruption by cytotoxic amyloid oligomers formed by prion protein(106-126) is dependent on bilayer composition.

Authors:  Patrick Walsh; Gillian Vanderlee; Jason Yau; Jody Campeau; Valerie L Sim; Christopher M Yip; Simon Sharpe
Journal:  J Biol Chem       Date:  2014-02-19       Impact factor: 5.157

Review 8.  A potential role for apoptosis in neurodegeneration and Alzheimer's disease.

Authors:  C W Cotman; A J Anderson
Journal:  Mol Neurobiol       Date:  1995-02       Impact factor: 5.590

9.  Monoclonal antibody F89/160.1.5 defines a conserved epitope on the ruminant prion protein.

Authors:  K I O'Rourke; T V Baszler; J M Miller; T R Spraker; I Sadler-Riggleman; D P Knowles
Journal:  J Clin Microbiol       Date:  1998-06       Impact factor: 5.948

10.  Prion peptide induces neuronal cell death through a pathway involving glycogen synthase kinase 3.

Authors:  Mar Pérez; Ana I Rojo; Francisco Wandosell; Javier Díaz-Nido; Jesús Avila
Journal:  Biochem J       Date:  2003-05-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.